Literature DB >> 24076600

BMP signaling controls muscle mass.

Roberta Sartori1, Elija Schirwis, Bert Blaauw, Sergia Bortolanza, Jinghui Zhao, Elena Enzo, Amalia Stantzou, Etienne Mouisel, Luana Toniolo, Arnaud Ferry, Sigmar Stricker, Alfred L Goldberg, Sirio Dupont, Stefano Piccolo, Helge Amthor, Marco Sandri.   

Abstract

Cell size is determined by the balance between protein synthesis and degradation. This equilibrium is affected by hormones, nutrients, energy levels, mechanical stress and cytokines. Mutations that inactivate myostatin lead to excessive muscle growth in animals and humans, but the signals and pathways responsible for this hypertrophy remain largely unknown. Here we show that bone morphogenetic protein (BMP) signaling, acting through Smad1, Smad5 and Smad8 (Smad1/5/8), is the fundamental hypertrophic signal in mice. Inhibition of BMP signaling causes muscle atrophy, abolishes the hypertrophic phenotype of myostatin-deficient mice and strongly exacerbates the effects of denervation and fasting. BMP-Smad1/5/8 signaling negatively regulates a gene (Fbxo30) that encodes a ubiquitin ligase required for muscle loss, which we named muscle ubiquitin ligase of the SCF complex in atrophy-1 (MUSA1). Collectively, these data identify a critical role for the BMP pathway in adult muscle maintenance, growth and atrophy.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24076600     DOI: 10.1038/ng.2772

Source DB:  PubMed          Journal:  Nat Genet        ISSN: 1061-4036            Impact factor:   38.330


  34 in total

1.  Regulation of skeletal muscle mass in mice by a new TGF-beta superfamily member.

Authors:  A C McPherron; A M Lawler; S J Lee
Journal:  Nature       Date:  1997-05-01       Impact factor: 49.962

Review 2.  RINGs of good and evil: RING finger ubiquitin ligases at the crossroads of tumour suppression and oncogenesis.

Authors:  Stanley Lipkowitz; Allan M Weissman
Journal:  Nat Rev Cancer       Date:  2011-08-24       Impact factor: 60.716

3.  Regulation of myostatin activity and muscle growth.

Authors:  S J Lee; A C McPherron
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-17       Impact factor: 11.205

Review 4.  Noggin.

Authors:  Carola Krause; Asja Guzman; Petra Knaus
Journal:  Int J Biochem Cell Biol       Date:  2011-01-21       Impact factor: 5.085

5.  The Spemann organizer signal noggin binds and inactivates bone morphogenetic protein 4.

Authors:  L B Zimmerman; J M De Jesús-Escobar; R M Harland
Journal:  Cell       Date:  1996-08-23       Impact factor: 41.582

Review 6.  Molecular and cellular determinants of skeletal muscle atrophy and hypertrophy.

Authors:  Vittorio Sartorelli; Marcella Fulco
Journal:  Sci STKE       Date:  2004-07-27

7.  Smad2 and 3 transcription factors control muscle mass in adulthood.

Authors:  Roberta Sartori; Giulia Milan; Maria Patron; Cristina Mammucari; Bert Blaauw; Reimar Abraham; Marco Sandri
Journal:  Am J Physiol Cell Physiol       Date:  2009-04-08       Impact factor: 4.249

8.  Akt activation prevents the force drop induced by eccentric contractions in dystrophin-deficient skeletal muscle.

Authors:  Bert Blaauw; Cristina Mammucari; Luana Toniolo; Lisa Agatea; Reimar Abraham; Marco Sandri; Carlo Reggiani; Stefano Schiaffino
Journal:  Hum Mol Genet       Date:  2008-08-27       Impact factor: 6.150

Review 9.  Signaling in muscle atrophy and hypertrophy.

Authors:  Marco Sandri
Journal:  Physiology (Bethesda)       Date:  2008-06

10.  The bone morphogenetic protein axis is a positive regulator of skeletal muscle mass.

Authors:  Catherine E Winbanks; Justin L Chen; Hongwei Qian; Yingying Liu; Bianca C Bernardo; Claudia Beyer; Kevin I Watt; Rachel E Thomson; Timothy Connor; Bradley J Turner; Julie R McMullen; Lars Larsson; Sean L McGee; Craig A Harrison; Paul Gregorevic
Journal:  J Cell Biol       Date:  2013-10-21       Impact factor: 10.539

View more
  191 in total

Review 1.  Innervation and neuromuscular control in ageing skeletal muscle.

Authors:  Russell T Hepple; Charles L Rice
Journal:  J Physiol       Date:  2015-12-21       Impact factor: 5.182

2.  Dach2-Hdac9 signaling regulates reinnervation of muscle endplates.

Authors:  Peter C D Macpherson; Pershang Farshi; Daniel Goldman
Journal:  Development       Date:  2015-10-19       Impact factor: 6.868

Review 3.  Fat deposition and accumulation in the damaged and inflamed skeletal muscle: cellular and molecular players.

Authors:  Clara Sciorati; Emilio Clementi; Angelo A Manfredi; Patrizia Rovere-Querini
Journal:  Cell Mol Life Sci       Date:  2015-02-18       Impact factor: 9.261

4.  Loss of BMPR2 leads to high bone mass due to increased osteoblast activity.

Authors:  Jonathan W Lowery; Giuseppe Intini; Laura Gamer; Sutada Lotinun; Valerie S Salazar; Satoshi Ote; Karen Cox; Roland Baron; Vicki Rosen
Journal:  J Cell Sci       Date:  2015-02-06       Impact factor: 5.285

Review 5.  Proteotoxicity: an underappreciated pathology in cardiac disease.

Authors:  Marco Sandri; Jeffrey Robbins
Journal:  J Mol Cell Cardiol       Date:  2013-12-28       Impact factor: 5.000

6.  CIR-Myo News: Proceedings of the 2014 Spring Padua Muscle Days: Terme Euganee and Padova (Italy), April 3-5, 2014.

Authors: 
Journal:  Eur J Transl Myol       Date:  2014-03-27

7.  Changes in skeletal muscle and tendon structure and function following genetic inactivation of myostatin in rats.

Authors:  Christopher L Mendias; Evan B Lynch; Jonathan P Gumucio; Michael D Flood; Danielle S Rittman; Douglas W Van Pelt; Stuart M Roche; Carol S Davis
Journal:  J Physiol       Date:  2015-02-25       Impact factor: 5.182

8.  BMP signaling regulates satellite cell-dependent postnatal muscle growth.

Authors:  Amalia Stantzou; Elija Schirwis; Sandra Swist; Sonia Alonso-Martin; Ioanna Polydorou; Faouzi Zarrouki; Etienne Mouisel; Cyriaque Beley; Anaïs Julien; Fabien Le Grand; Luis Garcia; Céline Colnot; Carmen Birchmeier; Thomas Braun; Markus Schuelke; Frédéric Relaix; Helge Amthor
Journal:  Development       Date:  2017-07-10       Impact factor: 6.868

Review 9.  Skeletal muscle atrophy and the E3 ubiquitin ligases MuRF1 and MAFbx/atrogin-1.

Authors:  Sue C Bodine; Leslie M Baehr
Journal:  Am J Physiol Endocrinol Metab       Date:  2014-08-05       Impact factor: 4.310

10.  mTOR inhibition and BMP signaling act synergistically to reduce muscle fibrosis and improve myofiber regeneration.

Authors:  Shailesh Agarwal; David Cholok; Shawn Loder; John Li; Christopher Breuler; Michael T Chung; Hsiao Hsin Sung; Kavitha Ranganathan; Joe Habbouche; James Drake; Joshua Peterson; Caitlin Priest; Shuli Li; Yuji Mishina; Benjamin Levi
Journal:  JCI Insight       Date:  2016-12-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.